153 related articles for article (PubMed ID: 37495012)
21. Practical and Science-Based Strategy for Establishing Acceptable Intakes for Drug Product
Dobo KL; Kenyon MO; Dirat O; Engel M; Fleetwood A; Martin M; Mattano S; Musso A; McWilliams JC; Papanikolaou A; Parris P; Whritenour J; Yu S; Kalgutkar AS
Chem Res Toxicol; 2022 Mar; 35(3):475-489. PubMed ID: 35212515
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo mammalian mutation assays support a nonmutagenic mechanism of carcinogenicity for hydrazine.
Nicolette J; Murray J; Sonders P; Kondratiuk A; Crosby M
Environ Mol Mutagen; 2021 Jan; 62(1):4-17. PubMed ID: 32951273
[TBL] [Abstract][Full Text] [Related]
23. Genotoxicity assessments of N-nitrosoethylisopropylamine (NEIPA) and N-nitrosodiisopropylamine (NDIPA) in the C57BL/6J mouse.
Ye Q; Geng X; Jiang H; Qin C; Wu H; Wang S; Wen H
Mutat Res Genet Toxicol Environ Mutagen; 2024; 896():503763. PubMed ID: 38821676
[TBL] [Abstract][Full Text] [Related]
24. The relationship between the carcinogenicity and mutagenicity of nitrosamines in a hepatocyte-mediated mutagenicity assay.
Jones CA; Marlino PJ; Lijinsky W; Huberman E
Carcinogenesis; 1981; 2(10):1075-7. PubMed ID: 7296760
[TBL] [Abstract][Full Text] [Related]
25. 7-azabicyclo[2.2.1]heptane as a structural motif to block mutagenicity of nitrosamines.
Ohwada T; Ishikawa S; Mine Y; Inami K; Yanagimoto T; Karaki F; Kabasawa Y; Otani Y; Mochizuki M
Bioorg Med Chem; 2011 Apr; 19(8):2726-41. PubMed ID: 21435887
[TBL] [Abstract][Full Text] [Related]
26. EURL ECVAM Genotoxicity and Carcinogenicity Database of Substances Eliciting Negative Results in the Ames Test: Construction of the Database.
Madia F; Kirkland D; Morita T; White P; Asturiol D; Corvi R
Mutat Res Genet Toxicol Environ Mutagen; 2020; 854-855():503199. PubMed ID: 32660827
[TBL] [Abstract][Full Text] [Related]
27. Determination of a positive response in the Ames Salmonella mutagenicity assay.
Zeiger E
Environ Mol Mutagen; 2023 Apr; 64(4):250-258. PubMed ID: 36916210
[TBL] [Abstract][Full Text] [Related]
28. DeepAmes: A deep learning-powered Ames test predictive model with potential for regulatory application.
Li T; Liu Z; Thakkar S; Roberts R; Tong W
Regul Toxicol Pharmacol; 2023 Oct; 144():105486. PubMed ID: 37633327
[TBL] [Abstract][Full Text] [Related]
29. Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA).
Kruhlak NL; Schmidt M; Froetschl R; Graber S; Haas B; Horne I; Horne S; King ST; Koval IA; Kumaran G; Langenkamp A; McGovern TJ; Peryea T; Sanh A; Siqueira Ferreira A; van Aerts L; Vespa A; Whomsley R
Regul Toxicol Pharmacol; 2024 Jun; 150():105640. PubMed ID: 38754805
[TBL] [Abstract][Full Text] [Related]
30. Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA).
Bercu JP; Masuda-Herrera M; Johnson G; Czich A; Glowienke S; Kenyon M; Thomas R; Ponting DJ; White A; Cross K; Waechter F; Rodrigues MAC
Regul Toxicol Pharmacol; 2021 Jul; 123():104926. PubMed ID: 33862169
[TBL] [Abstract][Full Text] [Related]
31. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
[TBL] [Abstract][Full Text] [Related]
32. The gradient plate assay: a modified Ames assay used as a prescreen for the identification of bacterial mutagens.
Rexroat MA; Oberly TJ; Bewsey BJ; Garriott ML
Mutat Res; 1995 Jan; 341(3):185-92. PubMed ID: 7529359
[TBL] [Abstract][Full Text] [Related]
33. The mouse spot test. Evaluation of its performance in identifying chemical mutagens and carcinogens.
Styles JA; Penman MG
Mutat Res; 1985 Nov; 154(3):183-204. PubMed ID: 3900714
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
Kirkland D; Aardema M; Müller L; Makoto H
Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
[TBL] [Abstract][Full Text] [Related]
35. Predicting rodent carcinogenicity from mutagenic potency measured in the Ames Salmonella assay.
Fetterman BA; Kim BS; Margolin BH; Schildcrout JS; Smith MG; Wagner SM; Zeiger E
Environ Mol Mutagen; 1997; 29(3):312-22. PubMed ID: 9142175
[TBL] [Abstract][Full Text] [Related]
36. The Ames Salmonella/microsome mutagenicity assay.
Mortelmans K; Zeiger E
Mutat Res; 2000 Nov; 455(1-2):29-60. PubMed ID: 11113466
[TBL] [Abstract][Full Text] [Related]
37. Characterization of false positive, contaminant-driven mutagenicity in impurities associated with the sotorasib drug substance.
Coppi A; Davies R; Wegesser T; Ishida K; Karmel J; Han J; Aiello F; Xie Y; Corbett MT; Parsons AT; Monticello TM; Minocherhomji S
Regul Toxicol Pharmacol; 2022 Jun; 131():105162. PubMed ID: 35331777
[TBL] [Abstract][Full Text] [Related]
38. Metabolic activation of short-chain alkyl N-nitrosamines using Aroclor 1254 or phenobarbital/beta-naphthoflavone-induced rat or hamster S9 - A comparative analysis.
Dieckhoff J; Bringezu F; Simon S
Toxicol Rep; 2024 Jun; 12():215-223. PubMed ID: 38322170
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the miniaturized liquid Ames microplate format (MPF™) for a selection of the test items from the recommended list of genotoxic and non-genotoxic chemicals.
Spiliotopoulos D; Koelbert C
Mutat Res Genet Toxicol Environ Mutagen; 2020; 856-857():503218. PubMed ID: 32928366
[TBL] [Abstract][Full Text] [Related]
40. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.
McMahon RE; Cline JC; Thompson CZ
Cancer Res; 1979 Mar; 39(3):682-93. PubMed ID: 371791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
